A preliminary field evaluation of ultraviolet - activated fluorescent roadway delineation von MAHACH, K.R, KNOBLAUCH, R.L, SIMMONS, M, ARENS, J.B, TIGNOR, S.C

Volltext

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients... von Jones, R.L., Demetri, G.D., Schuetze, S.M., Milhem, M., Elias, A., Van Tine, B.A., Hamm, J., McCarthy, S., Wang, G., Parekh, T., Knoblauch, R., Hensley, M.L., Maki, R.G., Patel, S., von Mehren, M.

Volltext

Efficacy and safety of trabectedin in an elderly patient subgroup (≥65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) from the Expanded Access Program (EAP) von Jones, R.L., Maki, R., Patel, S., Wang, G., Shin, C.R., Knoblauch, R., Demetri, G.D.S.

Volltext

Efficacy and safety of trabectedin or dacarbazine for the treatment of patients with uterine leiomyosarcoma after prior chemotherapy: A subgroup analysis of the randomized phase 3... von Hensley, M.L, Patel, S.R, Mehren, M.V, Ganjoo, K, Jones, R.L, Staddon, A.P, Rushing, D, Milhem, M, Monk, B.J, Wang, G, McCarthy, S, Knoblauch, R, Parekh, T, Maki, R.G, Demetri, G.D

Volltext

1321 Efficacy and safety of trabectedin (T) or dacarbazine (D) in an elderly patient subgroup (65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) after prior chemoth... von Von Mehren, M, Demetri, G.D, Schuetze, S.M, Jones, R.L, Milhem, M, Elias, A, Van Tine, B.A, Hamm, J, Khokhar, N.Z, McCarthy, S, Park, Y.C, Knoblauch, R.E, Parekh, T.V, Maki, R.G, Patel, S.R

Volltext

Efficacy and safety of patients treated long-term with trabectedin (t) on the expanded access program: A retrospective analysis von Davis, E., Schuetze, S., Patel, S., Maki, R., Jones, R.L., Shin, C.R., Knoblauch, R., Wang, G., Smith, M., Demetri, G.D.S., Merriam, P.

Volltext